Short name: AMI-25, generic name: Ferumoxide (SPIO)
Ferumoxides are superparamagnetic (
T2*)
MRI contrast agents, so the largest signal change is on T2 and
T2* weighted images.
The agent distributes relatively
rapidly to organs with reticuloendothelial cells primarily the
liver, spleen and bone marrow.
The
liver shows decreased
signal intensity, as does the spleen and marrow. The agent is taken up by the normal
liver, resulting in increased
CNR between tumor and normal
liver. Hepatocellular lesions, such as adenoma or focal nodular hyperplasia, contain reticuloendothelial cells, so they will behave similar to the
liver, with decreased signal on
T2 weighted images. On T1 images, there is typically some circulating
contrast agent, and blood vessels show increased
signal intensity.
Current
MRI protocols involve
T1 weighted breath-hold
gradient echo images of the
liver, and
fast spin echo T2 weighted pictures. This requires about 15 minutes. The patient is then removed from the scanner, and the
contrast agent administered. After
contrast administration, the same pulse
sequences are again repeated.